Ausgabe 6/2016
Inhalt (23 Artikel)
Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer
Radmila Lemstrova, Bohuslav Melichar, Beatrice Mohelnikova-Duchonova
Application of bee venom and its main constituent melittin for cancer treatment
Cui-cui Liu, Ding-jun Hao, Qian Zhang, Jing An, Jing-jing Zhao, Bo Chen, Ling-ling Zhang, Hao Yang
Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer
May Garrett, Timothy Taylor, Diane R. Mould, Michael A. Amantea, Ying Chen, Antonella Ingrosso, Yazdi K. Pithavala
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle
Ziyou Wang, Hua Zhang, Jiahui Zhou, Xiangning Zhang, Liyong Chen, Kangxing Chen, Zunnan Huang
Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells
Guodong He, Chen Feng, Rajamanickam Vinothkumar, Weiqian Chen, Xuanxuan Dai, Xi Chen, Qingqing Ye, Chenyu Qiu, Huiping Zhou, Yi Wang, Guang Liang, Yubo Xie, Wei Wu
GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis
Xiangzhen Kong, Zihao Li, Xian Li
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial
Miriam Krischke, Georg Hempel, Swantje Völler, Nicolas André, Maurizio D’Incalci, Gianni Bisogno, Wolfgang Köpcke, Matthias Borowski, Ralf Herold, Alan V. Boddy, Joachim Boos
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function
Analía Azaro, Jordi Rodón, Jean-Pascal Machiels, Sylvie Rottey, Silvia Damian, Richard Baird, Javier Garcia-Corbacho, Ron H. J. Mathijssen, Pierre-François Clot, Claudine Wack, Liji Shen, Maja J. A. de Jonge
RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
Chenggang Li, Zhiming Zhao, Zhipeng Zhou, Rong Liu
Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane
Motoo Nomura, Satoru Iwasa, Takahiro Tsushima, Ken Kato, Hirofumi Yasui, Narikazu Boku, Manabu Muto, Kei Muro
Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma
Jamie E. Flerlage, Monika L. Metzger, Jianrong Wu, John C. Panetta
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation
Brian F. Kiesel, Robert A. Parise, Jianxia Guo, Donna M. Huryn, Paul A. Johnston, Raffaele Colombo, Malabika Sen, Jennifer R. Grandis, Jan H. Beumer, Julie L. Eiseman
Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma
Chaitali Passey, Raymond Darbenzio, Ying-Ming Jou, Mark Lynch, Manish Gupta
18F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen
Matthew Scarpelli, Justine Yang Bruce, Lakeesha Carmichael, Jens Eickhoff, Jill Kolesar, Scott Perlman, Robert Jeraj, Glenn Liu
Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial
Tadamichi Denda, Mitsuro Kanda, Yoshitaka Morita, Ho Min Kim, Tomomi Kashiwada, Chu Matsuda, Shinji Fujieda, Ken Nakata, Kenta Murotani, Koji Oba, Junichi Sakamoto, Hideyuki Mishima
Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer
In Hee Lee, Soo Jung Lee, Byung Woog Kang, Yee Soo Chae, Dongwon Baek, Soyoon Hwang, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu Seog Choi, Jae Chul Kim, Jong Gwang Kim
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037
Emma J. Haagensen, Huw D. Thomas, Wolfgang A. Schmalix, Andrew C. Payne, Lara Kevorkian, Rodger A. Allen, Paul Bevan, Ross J. Maxwell, David R. Newell
Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
T. Ebata, M. Yunokawa, S. Bun, A. Shimomura, T. Shimoi, M. Kodaira, K. Yonemori, C. Shimizu, Y. Fujiwara, T. Kato, K. Tamura
Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity
Zhiqiang Zhang, Yunmin Wang, Jiehan Chen, Qijia Tan, Caijun Xie, Cong Li, Wengang Zhan, Mei Wang
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer
Benjamin L. Maughan, Daniel L. Suzman, Brandon Luber, Hao Wang, Stephanie Glavaris, Robert Hughes, Rana Sullivan, Rana Harb, Karim Boudadi, Channing Paller, Mario Eisenberger, Angelo Demarzo, Ashely Ross, Emmanuel S. Antonarakis
EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases
Jing Zhao, Xin Ye, Yan Xu, Minjiang Chen, Wei Zhong, Yun Sun, Zhenfan Yang, Guanshan Zhu, Yi Gu, Mengzhao Wang
Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice
Labidi Soumaya, Mejri Nesrine, El Benna Houda, Afrit Mehdi, Lakhdhar Sarra, Boussen Hamouda
Gota et al. on their article “the pharmacokinetics of Reditux™, a biosimilar of rituximab”
Mira Tout, Christophe Passot, Guillaume Cartron, Gilles Paintaud, David Ternant